Wellington Management Group
ATXS

Wellington Management Group’s Astria Therapeutics ATXS Stock Holding History

Wellington Management Group’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-145,433
Closed -$1.06M – 1931
2025
Q3 		$1.06M Sell
145,433
-48,316
-25% -$327K ﹤0.01% 1768
2025
Q2 		$1.04M Buy
193,749
+41,138
+27% +$199K ﹤0.01% 1715
2025
Q1 		$815K Buy
152,611
+4,562
+3% +$31.9K ﹤0.01% 1748
2024
Q4 		$1.32M Buy
148,049
+550
+0.4% +$5.84K ﹤0.01% 1664
2024
Q3 		$1.62M Buy
147,499
+11,763
+9% +$131K ﹤0.01% 1599
2024
Q2 		$1.24M Buy
135,736
+19,679
+17% +$192K ﹤0.01% 1626
2024
Q1 		$1.63M Buy
+116,057
New +$1.45M ﹤0.01% 1569
2017
Q1 		– Sell
-4,689
Closed -$1.02M – 2239
2016
Q4 		$1.02M Sell
4,689
-590
-11% -$144K ﹤0.01% 1852
2016
Q3 		$1.95M Sell
5,279
-1,638
-24% -$432K ﹤0.01% 1653
2016
Q2 		$1.54M Sell
6,917
-76
-1% -$22.9K ﹤0.01% 1670
2016
Q1 		$2.12M Buy
6,993
+1,943
+38% +$670K ﹤0.01% 1586
2015
Q4 		$2.4M Hold
5,050
– – ﹤0.01% 1577
2015
Q3 		$2.45M Sell
5,050
-36
-0.7% -$25.7K ﹤0.01% 1571
2015
Q2 		$3.73M Buy
+5,086
New +$3.84M ﹤0.01% 1486

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group's ATXS Position: Q4 2025 in Review

Wellington Management Group sold out of Astria Therapeutics (ATXS) in Q4 2025, closing a stake of 145,433 shares — an estimated $1.06M sold.

Wellington Management Group first reported a position in ATXS in Q2 2015 and held it in 14 quarters. The position peaked at $3.73M in Q2 2015. 141 funds tracked by Wall St. Rank hold ATXS as of Q4 2025.

  • Wellington Management Group reported no remaining Astria Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Wellington Management Group sold 145,433 Astria Therapeutics shares in Q4 2025, an estimated $1.06M.
  • Wellington Management Group first reported a position in Astria Therapeutics in Q2 2015 and held it in 14 quarters.
  • Wellington Management Group's Astria Therapeutics position peaked at $3.73M in Q2 2015.
  • 141 funds tracked by Wall St. Rank held Astria Therapeutics as of Q4 2025.

Based on Wellington Management Group's 13F filing for Q4 2025, filed 17 Feb 2026.